Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cellceutix CTIX

Innovation Pharmaceuticals Inc is a clinical-stage pharmaceutical company in the United States. It is engaged in developing therapies with oncology, dermatology, and antimicrobial applications. Its clinical trials focus on evaluating its drug candidates, including Kevetrin for the treatment of cancers; Brilacidin, a potential therapeutic for the treatment of the novel coronavirus. The company focuses on developing small molecule therapies to treat diseases in the areas of cancer, antibiotics, an


GREY:CTIX - Post by User

Bullboard Posts
Post by jmhollenon Sep 11, 2009 1:26pm
454 Views
Post# 16297903

CTIX - Celluceutix Corporation

CTIX - Celluceutix CorporationCelluceutix Corporation (OTCBB CTIX):At Cellceutix, we have an exciting pipeline. We have the expertise of alarge pharmaceutical company, but we're also focused, nimble andwilling to supplement our own creative energies with ideas from theoutside. We're focused on our lead candidate, Kevetrin, which we planto develop for head and neck cancer. And we're focused on developinghigh quality data and patents to support Kevetrin. We're also open tonew ideas from outside as well as inside. As a matter of fact, ourpipeline already includes compounds licensed from the outside tosupplement those invented by one of our co-founders, Dr. Krishna Menon.We're willing to partner with anyone who will help us meet our goals.When you put all this together, it means we at Cellceutix have a veryexciting opportunity to create real value for our shareholders, as wellas for our ultimate customers, the patients.

Website:https://www.cellceutix.com/
.
Bullboard Posts